TuHURA Biosciences, Inc./NV (HURA) stock
HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.25−0.11 (-8.09%)
Close on Nov 20, 2026Market cap $79.66MP/E –Yield –
TuHURA Biosciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
TuHURA Biosciences's price to book ratio was 5.2× on Nov 11, 2026, against 6.1× a year earlier. Over the last 5 years it ranged from 0.2× to 13.6×, with a median of 0.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.2× | +2.9 |
| 2025 | Dec 31, 2025 | 2.3× | +2.1 |
| 2024 | Dec 31, 2024 | 0.3× | −0.1 |
| 2023 | Dec 29, 2023 | 0.4× | −0.5 |
| 2022 | Dec 30, 2022 | 0.8× | +0.0 |
| 2021 | Dec 31, 2021 | 0.8× | +0.0 |
| 2020 | Dec 31, 2020 | 0.8× | +0.4 |
| 2019 | Dec 31, 2019 | 0.4× | +0.3 |
| 2018 | Dec 31, 2018 | 0.1× | −1.0 |
| 2017 | Dec 29, 2017 | 1.1× | +0.3 |
| 2016 | Dec 30, 2016 | 0.8× | – |
See a number that looks wrong?